InsidersTradesSigma
东星医疗 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 东星医疗 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 东星医疗 has recorded 4 insider filings. Market capitalisation: €2.5bn. The latest transaction was reported on 7 January 2025 (Purchase). Among the most active insiders: 龚爱琴. Every trade is free.
4
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
0 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,049 of 25,451 companies
37.8
score / 100
Value37
Quality39
FCF yld1.3%
Earn yld-1.3%
EV/EBITDA·
ROE11%
Gross mgn49%
Net mgn-9.8%
Debt/EBITDA7.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 January 2025
Declarations4 total
4 of 4 declarations